Loading data
CELZNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6 k USD | 11 k USD | 9 k USD | 88.6 k USD | 87.75 k USD |
| Cost of revenue | 2.19 k USD | 4.4 k USD | 3.6 k USD | 28.49 k USD | 47.95 k USD |
| Gross profit | 3.81 k USD | 6.6 k USD | 5.4 k USD | 60.11 k USD | 39.81 k USD |
| Research and development expense | 2.26 m USD | 2.4 m USD | 1.97 m USD | 6.27 m USD | 109.18 k USD |
| Selling, general and administrative expense | 3.76 m USD | 3.24 m USD | 3.56 m USD | 3.94 m USD | 2.96 m USD |
| Operating profit | -6.14 m USD | -5.74 m USD | -5.62 m USD | -10.24 m USD | -3.13 m USD |
| Interest expense | — | — | — | 0 USD | 4.28 m USD |
| Profit before tax | -6 m USD | -5.49 m USD | -5.29 m USD | -10.14 m USD | 19.21 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 0 USD | 0 USD |
| Net income (reported basis) | -6 m USD | -5.49 m USD | -5.29 m USD | -10.14 m USD | 19.21 m USD |
| Basic earnings per share | — | — | — | -0.93 USD/share | 7.37 USD/share |
| Diluted earnings per share | -2.52 USD/share | -3.71 USD/share | -3.76 USD/share | -0.93 USD/share | 5.61 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.